Global Neurodegenerative Diseases Market 2015-2019

1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Neurodegenerative Diseases Market
2015-2019
2
Description
Report Overview
About neurodegenerative diseases According to the
EU JPND, neurodegenerative diseases refer to
conditions that involve the neurons in the brain.
These conditions can affect balance, movement,
speech, and respiratory and cardiac functions.
They can be inherited or be of unknown etiology.
Neurodegenerative diseases are incurable and are
severely debilitating. They result in progressive
degeneration of nerve cells, causing them to die
eventually. These diseases cause ataxia and
dementia in people, which can have a serious
impact on the mental health of patients. Some
examples of neurodegenerative diseases are
Alzheimers disease, Parkinsons disease,
Huntingtons disease, multiple sclerosis,
amyotrophic lateral sclerosis, and epilepsy.
Huntingtons disease and amyotrophic lateral
sclerosis are rare diseases, unlike Alzheimers
disease and Parkinsons disease which have a high
degree of prevalence. Global neurodegenerative
diseases market to grow at a CAGR of 4.77 percent
over the period 2014-2019. Read more details at
http//www.bigmarketresearch.com/global-neurodegen
erative-diseases-2015-2019-market
_at_Bigmarketresearch
3
Key Benefits
Description
This report covers the present scenario and the
growth prospects of the global neurodegenerative
diseases market for the period 2015-2019. To
calculate the market size, the report considers
revenue generated from the sales of various drugs
used in the treatment of neurodegenerative
diseases. The market includes data from the
sales of various drugs used in the treatment
of Alzheimer's Disease Parkinson's Disease
Multiple Sclerosis Epilepsy Huntington's
Disease Amyotrophic Lateral Sclerosis
_at_Bigmarketresearch
4
Description
The report also presents the vendor landscape and
a corresponding detailed analysis of the top
vendors in the global neurodegenerative diseases
market. The vendor landscape section includes a
market share analysis of the major vendors along
with the performances of their product
portfolios. In addition, it discusses the major
drivers that influence the growth of the market.
It also outlines the challenges faced by vendors
and the market at large, as well as the key
trends that are emerging in the market. In
addition, late-stage pipeline molecules developed
for the treatment of neurodegenerative diseases
are discussed. Global Neurodegenerative Diseases
Market 2015-2019, has been prepared based on an
in-depth market analysis with inputs from
industry experts. The report covers the Americas,
the EMEA, and the APAC it also covers the global
neurodegenerative diseases market landscape and
its growth prospects in the coming years. The
report also includes a discussion of the key
vendors operating in this market. Key Regions
Americas APAC EMEA
_at_Bigmarketresearch
5
Description
Key vendors Biogen Idec Merck Serono
Novartis Pfizer Teva Pharmaceutical
Industries UCB Other Prominent Vendors AB
Science Abbvie Acorda Therapeutics
Actavis Active Biotech Adamas
Pharmaceuticals Akorn Archer Pharmaceuticals
Astellas
_at_Bigmarketresearch
6
Table Of Contents
Table Of Content
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Product
Profiles 05. Market Research Methodology 05.1
Market Research Process 05.2 Research
Methodology 06. Introduction 07. Market
Landscape 08. Segmentation of Global
Neurodegenerative Diseases Market by Type of
Disease 09. Global Multiple Sclerosis Market 10.
Global Alzheimer's Disease Market Enquire About
Report _at_ http//www.bigmarketresearch.com/report-e
nquiry/222191
_at_Bigmarketresearch
7
Get Full Information At http//www.bigmarketrese
arch.com/global-neurodegenerative-diseases-2015-20
19-market